Back to discover
Disease

Dementia, Vascular

Late-stage therapeutic developmentEmerging researchSteady momentum
6
Publications
24
Clinical trials
3
Related conditions
2025
Latest publication

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Clinical Milestones15View all 15
+7 more in the activity timeline below
Activity timeline15

Clinical trials

12 sponsors · 1 new · 6 completed in the last 12 months (net -2)

The current development programme across all trial phases.

Clinical programme
24
All trials
6
Active
18
Late-stage
6
Completed
Late-stage studies
Recently completed

Research activity

6 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Publications over time
20102025
Most influential
Recent publications
Major themes8
  • Dementia, Vascular2
  • Neuronal Plasticity2
  • Alzheimer Disease1
  • Extracellular Vesicles1
  • Fluorodeoxyglucose F181
  • Hippocampus1
  • Memory Disorders1
  • Mental Disorders1
Leading journals6
  • Acta neuropathologica communications1
  • Arteriosclerosis, thrombosis, and vascular biology1
  • BMJ (Clinical research ed.)1
  • Brain and behavior1
  • Stroke1
  • The Lancet. Neurology1
Leading researchers8
  • Agosta F1
  • Arbizu J1
  • Arnett DK1
  • Barkhof F1
  • Barthel H1
  • Bennett DA1
  • Black SE1
  • Brooks DJ1
Affiliations (unnormalised)6
  • Alzheimer Center1
  • Amsterdam University Medical Center1
  • Beijing Key Laboratory of Sports Function Assessment and Technical Analysis1
  • Center for Alzheimer Research1
  • Center for Lifespan Changes in Brain and Cognition1
  • Centre des Maladies Cognitives et Comportementales1

Related conditions

3 matches

Diseases frequently studied alongside this one. Number shows shared papers.

Disease profile

A grounded synthesis of the condition — overview, causes, mechanism, risk factors and current standard of care.

Overview

Vascular dementia is an imprecise term for dementia associated with cerebrovascular disorders, including single or multiple cerebral infarctions and conditions linked to chronic brain ischemia. Described subtypes include diffuse, cortical, and subcortical forms. It is part of the broader spectrum of vascular contributions to cognitive impairment and dementia.

Causes

It is associated with cerebrovascular disorders, especially cerebral infarction and chronic brain ischemia. The literature also describes vascular components such as atherosclerosis, arterio(l)o sclerosis, microinfarcts, and amyloid angiopathy as contributors to cognitive decline in later life. Cerebrovascular disease is often present alongside other causes of dementia rather than acting as the sole cause.

Pathophysiology

The disease reflects cognitive impairment arising from vascular injury to the brain, including infarction and chronic ischemic damage. White matter hyperintensities are studied as imaging markers associated with stroke, cognitive decline, and dementia, consistent with underlying small-vessel and ischemic brain injury. The literature also highlights neuropathology, basic science, and pathophysiological aspects of vascular contributions to dementia, including neuronal plasticity as a co-studied mechanism.

Risk factors

A history of stroke increases later dementia risk, and the prevention of recurrent stroke is emphasized as a key preventive strategy. More broadly, vascular risk is linked to cerebrovascular disease and white matter hyperintensities, which are associated with cognitive decline and dementia. The literature also notes vascular and other associated risk factors in vascular cognitive impairment and dementia.

Current standard of care

Management is described at the level of prevention and treatment of vascular contributions to cognitive impairment and dementia, with emphasis on preventing and treating cerebrovascular disease. The reviewed literature highlights stroke prevention, including prevention of recurrent stroke, as a cornerstone. Diagnostic and management discussions also include neuroimaging and biomarker-based evaluation, but no specific drug class is established in the supplied grounding.

AI-generated summary grounded in MeSH and 4 peer-reviewed sources. Informational only — not medical advice. Generated 2026-07-07.

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

An imprecise term referring to dementia associated with CEREBROVASCULAR DISORDERS, including CEREBRAL INFARCTION (single or multiple), and conditions associated with chronic BRAIN ISCHEMIA. Diffuse, cortical, and subcortical subtypes have been described. (From Gerontol Geriatr 1998 Feb;31(1):36-44)

References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.